Category: General News
Search News
Prof Manchanda receives prestigious recognition from India’s leading medical school
17th March 2022
Congratulations to Professor Ranjit Manchanda from the CRUK Barts Centre who has been awarded the Distinguished Infosys Chair in Oncology at the All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Read more
Clinical study to investigate new personalised treatment for ovarian cancer
14th March 2022
Dr Michelle Lockley from Barts Cancer Institute at Queen Mary University of London has received funding from Barts Charity and the Anticancer Fund to investigate a new personalised treatment approach for ovarian cancer that has returned after previous chemotherapy.
Read more
Understanding the evolution of Barrett’s oesophagus to cancer
17th February 2022
February is Oesophageal Cancer Awareness Month. At Barts Cancer Institute, Queen Mary University of London, a key area of research focus is on a condition that can precede oesophageal cancer called Barrett’s oesophagus.
Read more
International Day of Women and Girls in Science
11th February 2022
This International Day of Women and Girls in Science, Radhisha Kohombage, an MSc student at BCI, spoke to some fellow students, to hear more about their roles, inspirations, and advice for the next generation who would like to pursue a career in science.
Read more
Breaking down language barriers in cancer
4th February 2022
Vinaya Srirangam Nadhamuni, Clinical Research Fellow at Barts Cancer Institute, Queen Mary University of London, has been working on a project to make information about screening programmes more accessible to minority ethnic groups in the UK.
Read more
Targeting healthy cells changes invasive behaviour of pancreatic cancer
25th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, led by Dr Angus Cameron, have found a way to modulate the invasive behaviour of pancreatic cancer by targeting a non-cancerous cell type found within pancreatic tumours. The findings, published in Cell Reports, provide valuable insights into the biology of pancreatic cancer progression, and could help to drive improvements in cancer treatment.
Read more